Facility Information

CRUISERATH, IRELAND
WORLDWIDE MEDICINES

Facts and Figures

Bristol-Myers Squibb (BMS) has further expanded its operations in Ireland through the development of the new manufacturing facility at Cruiserath, Mulhuddart, Dublin. This is a multifunctional, automated bulk pharmaceutical production facility, initially manufacturing medicines for blood pressure and hypertension. Construction commenced in 2000, and manufacturing started during the first quarter 2004.
Additional information about the facility can be found on the BMS Ireland website.

Economic Development

BMS Cruiserath has a team-based approach to its operations and selects employees likely to thrive in a standards-based, technically complex environment.

Community and Social Progress

Bristol Myers-Squibb Cruiserath places great emphasis on being a good neighbour to the people of Mulhuddart, Blanchardstown, Tyrellstown and Fingal. We hold meetings with local residents to share information and we are proud of our record of safe operations without any adverse environmental impact. In addition to the direct economic impact in the local area, the company supports worthwhile charities and is committed to maintaining excellent relationships with the local community.

BMS is a recognised leader in the field of Environment, Health and Safety (EHS) and has won numerous awards throughout the world for Sustainability, Safety and Health protection. The company is strongly committed to protecting the Environment and the Health and Safety of its employees, customers, and neighbours.
Comprehensive EHS management systems have been put in place to safeguard employees and neighbouring communities. As of August 2006 in excess of 1,000,000 hours were worked by BMS employees without a lost time accident.

Environmental Performance

The site is licensed and audited by the Environmental Protection Agency. This requires the facility to operate within rigorous management and operational controls as well as specified emission limits. The plant is also subject to auditing and inspection by the Health and Safety Authority, to regulate safety, its chemical inventory and have in place contingencies to deal with any possible accident or emergency.
Containment, abatement, and waste treatment systems installed at the facility are state-of-the-art, and conform to the highest Safety and Environmental protection standards, including strict controls specified in the Integrated Pollution Control License.

Energy Efficiency at BMS Cruiserath

Working with the Swords site, Cruiserath has completed a number of significant initiatives to reduce its energy consumption:
- In 2006 the site reduced liquid Nitrogen consumption on site by 45%
- In 2006 the operation of the site’s liquid/gaseous waste thermal treatment unit was optimized to reduce the natural gas required to run the unit by 16%
- In 2006 the operation of the site’s chiller system was optimized to give a 3% reduction in the sites electricity usage
- The implementation of a recycle project has meant site energy savings of 10% on gas and 2% on electricity to recover solvent.

Facility Contact Information

+353-1885-4000

(see also Bristol-Myers Squibb Ireland)

Last updated March 26, 2008 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

Facility Information:

Facts and Figures

Economic Development

Community and Social Progress

Environmental Performance

Facility Contact Information

Return to List of Facilities